S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

VTVT vTv Therapeutics Inc

22.00

-1.33 (-5.70%)

Jun 03 2024 - Closed

Delayed by 15 minutes

vTv Therapeutics GAAP EPS of -$0.11

To read the full story on Seeking Alpha, click here.

vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more vTv Therapeutics Charts.

vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more vTv Therapeutics Charts.

vTv Therapeutics Inc News

CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING
Tuesday 28 May 2024 (7 days ago) • PR Newswire (US)

vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
Thursday 9 May 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (4 weeks ago) • Edgar (US Regulatory)

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
Tuesday 19 March 2024 (3 months ago) • PR Newswire (US)

vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Wednesday 13 March 2024 (3 months ago) • GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities
Thursday 7 March 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Tuesday 5 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 5 March 2024 (3 months ago) • Edgar (US Regulatory)

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
Monday 4 March 2024 (3 months ago) • GlobeNewswire Inc.

vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
Friday 1 March 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 February 2024 (3 months ago) • Edgar (US Regulatory)

More vTv Therapeutics Inc News Articles

Fidelity Advisor Sustain...

Desjardins Alt Long Shor...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions